Department of Justice Awarded a Contract to ACTELION PHARMACEUTICALS US, INC. for $12,540.07

Q: Where is ACTELION PHARMACEUTICALS US, INC. located?

1125 TRENTON HARBOURTON RD # 1 TITUSVILLE NEW JERSEY UNITED STATES

Signed on

4/8/2025, 12:00 AM

ACTELION PHARMACEUTICALS US, INC. Government Contract #15B41825F00000180

ACTELION PHARMACEUTICALS US, INC. was awarded a contract with the United States Government for $12,540.07. The contract was awarded by the agency office USP TERRE HAUTE, which is a division with the Federal Prison System / Bureau of Prisons within the Department of Justice.

Summary of Award

The recipient of the federal contract is ACTELION PHARMACEUTICALS US, INC., a U.S.-owned business that specializes in pharmaceutical preparation manufacturing. The contract, with a total obligation of $12,540.07, was funded by the Department of Justice through the Federal Prison System / Bureau of Prisons for pharmaceutical products. One notable transaction from the list is a delivery order dated April 8, 2025, with a transaction amount matching the total obligation.

Contract Details

Contract ID15B41825F00000180

Contract TypeC

Total Obligation$12,540.07

Exercised Options$12,540.07

Base Amount + Options$12,540.07

Date Signed2025-04-08

Contract DescriptionFY25 B1 CURASCRIPT OPSUMIT MEDS APR25

Start Date2025-04-01

End Date2025-04-30

Agency Details

Awarding AgencyDepartment of Justice

Awarding Sub AgencyFederal Prison System / Bureau of Prisons

Awarding OfficeUSP TERRE HAUTE

Funding AgencyDepartment of Justice

Funding Sub AgencyFederal Prison System / Bureau of Prisons

Funding OfficeUSP TERRE HAUTE

Recipient Details

RecipientACTELION PHARMACEUTICALS US, INC.

Recipient Location1125 TRENTON HARBOURTON RD # 1 TITUSVILLE NEW JERSEY, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0 | $12,540.07April 8, 2025

Federal Prison System / Bureau of Prisons, a sub agency of Department of Justice, issued a payment of $12,540.07 to ACTELION PHARMACEUTICALS US, INC.. The payment included a Subsidy Cost of $0.00.